| scholarly article | Q13442814 |
| P50 | author | Ignacio Garrido-Laguna | Q71791712 |
| P2093 | author name string | Conan Kinsey | |
| Anna Torgeson | |||
| Shane Lloyd | |||
| Snehal Gajiwala | |||
| P2860 | cites work | Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation | Q26744490 |
| Sipuleucel-T immunotherapy for castration-resistant prostate cancer | Q27860648 | ||
| The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant | Q28081732 | ||
| Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase | Q28204166 | ||
| Idiotype vaccination as consolidation therapy: time for integration into standard of care for follicular lymphoma? | Q43053502 | ||
| Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. | Q46111623 | ||
| Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma | Q47551890 | ||
| Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype | Q48013101 | ||
| Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study | Q49925686 | ||
| Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer | Q49959323 | ||
| Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. | Q51803685 | ||
| Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. | Q54287306 | ||
| The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells | Q56902123 | ||
| Die Rolle der Strahlentherapie bei der Induktion von Antitumor-Immunantworten | Q61893824 | ||
| Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients | Q79323463 | ||
| B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression | Q80890589 | ||
| Abscopal effect in a patient with melanoma | Q84201850 | ||
| Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated | Q28245528 | ||
| The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance | Q28755302 | ||
| Cancer immunotherapy via dendritic cells | Q29615444 | ||
| Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine | Q29616728 | ||
| Immunologic correlates of the abscopal effect in a patient with melanoma | Q29620334 | ||
| Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. | Q33609699 | ||
| Immuno-oncology: understanding the function and dysfunction of the immune system in cancer | Q33859814 | ||
| Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. | Q33930593 | ||
| CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. | Q34279134 | ||
| Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. | Q35222367 | ||
| Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma | Q35587710 | ||
| IDO and tolerance to tumors | Q35628246 | ||
| Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients | Q35787792 | ||
| PD-1/PD-L1 inhibitors. | Q35893753 | ||
| The controversial abscopal effect | Q36143531 | ||
| CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer | Q37029731 | ||
| Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody | Q37351567 | ||
| Potential targets for pancreatic cancer immunotherapeutics | Q37861220 | ||
| Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies. | Q37993183 | ||
| Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. | Q38169428 | ||
| Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. | Q38393038 | ||
| Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial | Q38404655 | ||
| Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study | Q38459890 | ||
| Changing the course of pancreatic cancer--Focus on recent translational advances | Q38753998 | ||
| MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade | Q38788877 | ||
| The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer? | Q38875105 | ||
| PD-1 Restrains Radiotherapy-Induced Abscopal Effect. | Q38907646 | ||
| Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer | Q38975751 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report | Q39130681 | ||
| Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Q39190004 | ||
| Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy | Q39311439 | ||
| Pancreatic cancer: Update on immunotherapies and algenpantucel-L. | Q40261599 | ||
| CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative | Q40591372 | ||
| One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody | Q41521078 | ||
| Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. | Q41653193 | ||
| Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy | Q42118954 | ||
| Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer | Q42848515 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gastroenterology | Q120569 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 1014-1026 | |
| P577 | publication date | 2018-12-01 | |
| P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
| P1476 | title | Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle | |
| P478 | volume | 9 |
| Q92600987 | Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model |
| Q94602728 | Relationship between IL-10 and PD-L1 in esophageal carcinoma tissues and IL-10 down-regulates PD-L1 expression via Met signaling pathway |
| Q98159678 | Relationship between IL10 and PD-L1 in Liver Hepatocellular Carcinoma Tissue and Cell Lines |
| Q64967557 | The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors. |
| Q92627680 | Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments |
Search more.